ArticlePediatric blood & cancer2021

Veno-occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation.

Christine Duncan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.